Clinical trials: Stage IVB Liver Cancer

Advanced Adult Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma

Sorafenib Tosylate and Yttrium Y 90 Glass Microspheres in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

• Completed
• Age: 18 years and older
• Phase 2
• Surgery or procedure
• Results posted

This phase II trial studies how well sorafenib tosylate and yttrium Y 90 glass microspheres work in treating patients with liver cancer that cannot be removed by surgery.

Conditions

Advanced Adult Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Recurrent Adult Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v7

Trial name

NCT01900002

Testing

Laboratory Biomarker Analysis, Quality-of-Life Assessment, Sorafenib

Where

United States

Volunteers

40 people

Sponsor

M.D. Anderson Cancer Center